Occupational chronic obstructive pulmonary disease attributed to chemicals exposure: Clinical characteristics and inflammatory serum profile

Lyubov Shpagina (Novosibirsk, Russian Federation), Shpagina Lyubov, Olga Kotova, Ilya Shpagin, Oksana Gerasimenko

Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes
Session: Human responses to exposure, including physiological and biomarker outcomes
Session type: Poster Discussion
Number: 396
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lyubov Shpagina (Novosibirsk, Russian Federation), Shpagina Lyubov, Olga Kotova, Ilya Shpagin, Oksana Gerasimenko. Occupational chronic obstructive pulmonary disease attributed to chemicals exposure: Clinical characteristics and inflammatory serum profile. Eur Respir J 2016; 48: Suppl. 60, 396

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Molecular and cytological features of occupational chronic obstructive pulmonary disease in subjects exposed to different environmental factors
Source: International Congress 2015 – Occupational factors in COPD and bronchitis
Year: 2015


Genetic variability and occupational chronic obstructive pulmonary disease in subjects exposed to different environmental factors
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014


Medical and demographic loss of population due to chronic obstructive pulmonary disease
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016


Prevalence of occupational and environmental exposures in Australian patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – Occupational asthma, abestosis and silicosis
Year: 2014

Clinical features of chronic obstructive pulmonary disease in never smokers
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016

Occupational organic dust exposure and risk of chronic obstructive pulmonary disease (COPD) in Denmark
Source: International Congress 2015 – Occupational factors in COPD and bronchitis
Year: 2015


Characteristics and consequences of chronic obstructive pulmonary disease in never smokers
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013

Clinical characteristics and health burden of patients with chronic obstructive pulmonary disease exacerbation
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015

Occupational exposures and COPD: an ecological analysis of international data
Source: Eur Respir J 2009; 33: 298-304
Year: 2009



Nutritional status in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014


Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014

Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013


Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014


Impact of airflow obstruction severity on the course of COPD during follow-up
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014


Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014


Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

Chronic obstructive pulmonary disease phenotypes, nutritional status and the risk of falls
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016


Social and environmental determinants of physical activity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Measuring physical activity in chronic respiratory disease
Year: 2016